David H. Bollinger

Array ( [id] => 1299252 [patent_doc_number] => 06623962 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Enzymatic nucleic acid treatment of diseases of conditions related to levels of epidermal growth factor receptors' [patent_app_type] => B1 [patent_app_number] => 09/401063 [patent_app_country] => US [patent_app_date] => 1999-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 26548 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623962.pdf [firstpage_image] =>[orig_patent_app_number] => 09401063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1508449 [patent_doc_number] => 06441151 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Plant prohibition genes and their use' [patent_app_type] => B1 [patent_app_number] => 09/395674 [patent_app_country] => US [patent_app_date] => 1999-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20907 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/441/06441151.pdf [firstpage_image] =>[orig_patent_app_number] => 09395674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407604 [patent_doc_number] => 06309882 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Antisense inhibition of replication protein a p70 subunit' [patent_app_type] => 1 [patent_app_number] => 9/393529 [patent_app_country] => US [patent_app_date] => 1999-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19795 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309882.pdf [firstpage_image] =>[orig_patent_app_number] => 393529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086005 [patent_doc_number] => 06133032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Antisense modulation of PI3 kinase p110 beta expression' [patent_app_type] => 1 [patent_app_number] => 9/392350 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27704 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133032.pdf [firstpage_image] =>[orig_patent_app_number] => 392350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6327044 [patent_doc_number] => 20020197737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'NOVEL METHODS FOR TESTING INHIBITORS OF PAIRED HELICAL FILAMENTS AND USES FOR TREATMENT OF ALZHEIMER\'S DISEASE' [patent_app_type] => new [patent_app_number] => 09/319812 [patent_app_country] => US [patent_app_date] => 1999-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6894 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197737.pdf [firstpage_image] =>[orig_patent_app_number] => 09319812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761907 [patent_doc_number] => 20030125269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'T-TYPE CALCIUM CHANNEL' [patent_app_type] => new [patent_app_number] => 09/383894 [patent_app_country] => US [patent_app_date] => 1999-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21272 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125269.pdf [firstpage_image] =>[orig_patent_app_number] => 09383894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248121 [patent_doc_number] => 06673631 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Simultaneous isolation and quantitation of DNA' [patent_app_type] => B1 [patent_app_number] => 09/377986 [patent_app_country] => US [patent_app_date] => 1999-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16085 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673631.pdf [firstpage_image] =>[orig_patent_app_number] => 09377986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085977 [patent_doc_number] => 06133031 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Antisense inhibition of focal adhesion kinase expression' [patent_app_type] => 1 [patent_app_number] => 9/377310 [patent_app_country] => US [patent_app_date] => 1999-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21401 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133031.pdf [firstpage_image] =>[orig_patent_app_number] => 377310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186780 [patent_doc_number] => 06150515 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Tat-SF: cofactor for stimulation of transcriptional elongation by HIV-1 Tat' [patent_app_type] => 1 [patent_app_number] => 9/214564 [patent_app_country] => US [patent_app_date] => 1999-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 20965 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150515.pdf [firstpage_image] =>[orig_patent_app_number] => 214564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543823 [patent_doc_number] => 06372961 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Hemoglobin genes and their use' [patent_app_type] => B1 [patent_app_number] => 09/376728 [patent_app_country] => US [patent_app_date] => 1999-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11990 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372961.pdf [firstpage_image] =>[orig_patent_app_number] => 09376728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4194336 [patent_doc_number] => 06130324 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Amphipathic oligonucleotides and polynucleotides having potent antiviral activity' [patent_app_type] => 1 [patent_app_number] => 9/371909 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5965 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130324.pdf [firstpage_image] =>[orig_patent_app_number] => 371909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404071 [patent_doc_number] => 06228345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'In vivo assay for intravasation' [patent_app_type] => 1 [patent_app_number] => 9/366840 [patent_app_country] => US [patent_app_date] => 1999-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 8571 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228345.pdf [firstpage_image] =>[orig_patent_app_number] => 366840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141107 [patent_doc_number] => 06030837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Antisense inhibition of PEPCK-mitochondrial expression' [patent_app_type] => 1 [patent_app_number] => 9/366257 [patent_app_country] => US [patent_app_date] => 1999-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26189 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030837.pdf [firstpage_image] =>[orig_patent_app_number] => 366257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404303 [patent_doc_number] => 06171795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Nucleic acid ligands to CD40ligand' [patent_app_type] => 1 [patent_app_number] => 9/364380 [patent_app_country] => US [patent_app_date] => 1999-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6898 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171795.pdf [firstpage_image] =>[orig_patent_app_number] => 364380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477371 [patent_doc_number] => 06344321 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met' [patent_app_type] => B1 [patent_app_number] => 09/364539 [patent_app_country] => US [patent_app_date] => 1999-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 32 [patent_no_of_words] => 19126 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344321.pdf [firstpage_image] =>[orig_patent_app_number] => 09364539 [rel_patent_id] =>[rel_patent_doc_number] =>)